Zebularine and Trichostatin A sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent due to its selective killing on cancer cells while sparing the normal cells. Nevertheless, breast adenocarcinoma cells can develop TRAIL resistance. Therefore, this project investigated the anti-...

Full description

Bibliographic Details
Main Authors: Kong, Wei Yang, Yee, Zong Yang, Mai, Chun Wai, Fang, Chee Mun, Abdullah, Syahril, Ngai, Siew Ching
Format: Article
Language:English
Published: Elsevier 2019
Online Access:http://psasir.upm.edu.my/id/eprint/82773/
http://psasir.upm.edu.my/id/eprint/82773/1/Zebularine%20and%20trichostatin%20A%20.pdf
_version_ 1848859350111617024
author Kong, Wei Yang
Yee, Zong Yang
Mai, Chun Wai
Fang, Chee Mun
Abdullah, Syahril
Ngai, Siew Ching
author_facet Kong, Wei Yang
Yee, Zong Yang
Mai, Chun Wai
Fang, Chee Mun
Abdullah, Syahril
Ngai, Siew Ching
author_sort Kong, Wei Yang
building UPM Institutional Repository
collection Online Access
description Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent due to its selective killing on cancer cells while sparing the normal cells. Nevertheless, breast adenocarcinoma cells can develop TRAIL resistance. Therefore, this project investigated the anti-cancer effects of the combination of epigenetic drugs zebularine and trichostatin A (ZT) with TRAIL (TZT) on the human breast adenocarcinoma cells. This treatment regimen was compared with the natural anti-cancer compound curcumin (Cur) and standard chemotherapeutic drug doxorubicin (Dox). As compared to TRAIL treatment, TZT treatment hampered the cell viability of human breast adenocarcinoma cells MDA-MB-231 significantly but not MCF-7 and immortalized non-cancerous human breast epithelial cells MCF10A. Unlike TZT, Cur and Dox treatments reduced cell viability in both human breast adenocarcinoma and epithelial cells significantly. Nevertheless, there were no changes in cell cycle in both TRAIL and TZT treatments in breast adenocarcinoma and normal epithelial cells. Intriguingly, Cur and Dox treatment generally induced G2/M arrest in MDA-MB-231, MCF-7 and MCF10A but Cur induced S phase arrest in MCF10A. The features of apoptosis such as morphological changes, apoptotic activity and the expression of cleaved poly (ADP) ribose polymerase (PARP) protein were more prominent in TRAIL and TZT-treated MDA-MB-231 as compared to MCF10A at 24 h post-treatment. Compared to TZT treatment, Cur and Dox treatments exhibited lesser apoptotic features in MDA-MB-231. Collectively, the sensitization using Zeb and TSA to augment TRAIL-induced apoptosis might be an alternative therapy towards human breast adenocarcinoma cells, without harming the normal human breast epithelial cells.
first_indexed 2025-11-15T12:27:56Z
format Article
id upm-82773
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T12:27:56Z
publishDate 2019
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling upm-827732021-09-29T06:33:20Z http://psasir.upm.edu.my/id/eprint/82773/ Zebularine and Trichostatin A sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis Kong, Wei Yang Yee, Zong Yang Mai, Chun Wai Fang, Chee Mun Abdullah, Syahril Ngai, Siew Ching Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent due to its selective killing on cancer cells while sparing the normal cells. Nevertheless, breast adenocarcinoma cells can develop TRAIL resistance. Therefore, this project investigated the anti-cancer effects of the combination of epigenetic drugs zebularine and trichostatin A (ZT) with TRAIL (TZT) on the human breast adenocarcinoma cells. This treatment regimen was compared with the natural anti-cancer compound curcumin (Cur) and standard chemotherapeutic drug doxorubicin (Dox). As compared to TRAIL treatment, TZT treatment hampered the cell viability of human breast adenocarcinoma cells MDA-MB-231 significantly but not MCF-7 and immortalized non-cancerous human breast epithelial cells MCF10A. Unlike TZT, Cur and Dox treatments reduced cell viability in both human breast adenocarcinoma and epithelial cells significantly. Nevertheless, there were no changes in cell cycle in both TRAIL and TZT treatments in breast adenocarcinoma and normal epithelial cells. Intriguingly, Cur and Dox treatment generally induced G2/M arrest in MDA-MB-231, MCF-7 and MCF10A but Cur induced S phase arrest in MCF10A. The features of apoptosis such as morphological changes, apoptotic activity and the expression of cleaved poly (ADP) ribose polymerase (PARP) protein were more prominent in TRAIL and TZT-treated MDA-MB-231 as compared to MCF10A at 24 h post-treatment. Compared to TZT treatment, Cur and Dox treatments exhibited lesser apoptotic features in MDA-MB-231. Collectively, the sensitization using Zeb and TSA to augment TRAIL-induced apoptosis might be an alternative therapy towards human breast adenocarcinoma cells, without harming the normal human breast epithelial cells. Elsevier 2019-09 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/82773/1/Zebularine%20and%20trichostatin%20A%20.pdf Kong, Wei Yang and Yee, Zong Yang and Mai, Chun Wai and Fang, Chee Mun and Abdullah, Syahril and Ngai, Siew Ching (2019) Zebularine and Trichostatin A sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis. Heliyon, 5 (9). pp. 1-7. ISSN 2405-8440 https://www.cell.com/heliyon/fulltext/S2405-8440(19)36128-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2405844019361286%3Fshowall%3Dtrue 10.1016/j.heliyon.2019.e02468
spellingShingle Kong, Wei Yang
Yee, Zong Yang
Mai, Chun Wai
Fang, Chee Mun
Abdullah, Syahril
Ngai, Siew Ching
Zebularine and Trichostatin A sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis
title Zebularine and Trichostatin A sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis
title_full Zebularine and Trichostatin A sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis
title_fullStr Zebularine and Trichostatin A sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis
title_full_unstemmed Zebularine and Trichostatin A sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis
title_short Zebularine and Trichostatin A sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis
title_sort zebularine and trichostatin a sensitised human breast adenocarcinoma cells towards tumour necrosis factor-related apoptosis inducing ligand (trail)-induced apoptosis
url http://psasir.upm.edu.my/id/eprint/82773/
http://psasir.upm.edu.my/id/eprint/82773/
http://psasir.upm.edu.my/id/eprint/82773/
http://psasir.upm.edu.my/id/eprint/82773/1/Zebularine%20and%20trichostatin%20A%20.pdf